<html xmlns="http://www.w3.org/1999/xhtml"><body><table class="table"><caption /><tr><th class="cell">Publication </th><th class="cell">Culture model </th><th class="cell">Cases </th><th class="cell">Cells </th><th class="cell">Summary of fndings </th></tr><tr><td class="cell">Chen</td><td class="cell">Fibroblasts → iPSC</td><td class="cell">Three cases BPD type 1</td><td class="cell">Forebrain phenotype</td><td class="cell">2547 genes expression diff. between BPD/healthy</td></tr><tr><td class="cell">et al. (2014)</td><td class="cell">Retroviral vector (OCT4,</td><td class="cell">2 Li+ responders, one</td><td class="cell">VGlut+</td><td class="cell">subjects’iPSC</td></tr><tr><td class="empty"></td><td class="cell">SOX2, KLF4, c-MYC)</td><td class="cell">non-responder</td><td class="cell">pyramidal-shaped</td><td class="cell">186 genes expression ↑BPD (&gt; 1.5 fold) in iPSC</td></tr><tr><td class="empty"></td><td class="cell">iPSC → NPC → iNeurons</td><td class="cell">three age-matched</td><td class="cell">neurons,</td><td class="cell">46 genes expression ↓BPD (&gt; 1.5 fold) in iPSC</td></tr><tr><td class="empty"></td><td class="cell">Embryoid body medium</td><td class="cell">healthy controls</td><td class="cell">GABA+ interneurons,</td><td class="cell">1312 genes expression diff. between BPD/healthy</td></tr><tr><td class="empty"></td><td class="cell">and neuron induction</td><td class="empty"></td><td class="cell">scattered serotonergic</td><td class="cell">subjects’iN</td></tr><tr><td class="empty"></td><td class="cell">medium</td><td class="empty"></td><td class="cell">and dopaminergic</td><td class="cell">140 genes expression ↑BPD (&gt; 1.5 fold) in iN</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">neurons</td><td class="cell">46 genes expression ↓BPD (&gt; 1.5 fold) in iN</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">BPD-derived neurons show higher expression of</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">DICER1, NKX2-1 and PAX2 but lower expression</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">of EMX2 and HOXA1,6,7</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Li+ pre-treatment reduces Ca++ transient and wave</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">amplitude in BPD-derived iNs compared to healthy</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">subject derived iNs</td></tr><tr><td class="cell">Wang</td><td class="cell">Fibroblasts direct conversion</td><td class="cell">Twelve cases BPD type 1</td><td class="cell">Heterogeneous cell</td><td class="cell">Cells derived from Li+ responders show</td></tr><tr><td class="cell">et al. (2014)</td><td class="cell">Lentiviral vector</td><td class="cell">and history of</td><td class="cell">population, no</td><td class="cell">greater adhesion than cells from</td></tr><tr><td class="empty"></td><td class="cell">(miRNA-9/9*-123,</td><td class="cell">Li+ treatment</td><td class="cell">capability to produce</td><td class="cell">Li+ non-responders as measured by</td></tr><tr><td class="empty"></td><td class="cell">NEUROD2, ASCL1,</td><td class="cell">Six responders</td><td class="cell">action potentials</td><td class="cell">ΔPWV (Peak Wave Length) in a BIND scanner</td></tr><tr><td class="empty"></td><td class="cell">MYT1L)</td><td class="cell">Six non-responders</td><td class="cell">without further</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Six healthy subjects</td><td class="cell">differentiation and</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">expressing neuronal</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">as well as stem-cell</td><td class="empty"></td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">markers</td><td class="empty"></td></tr><tr><td class="cell">Madison</td><td class="cell">Fibroblasts → iPSC</td><td class="cell">Two offspring</td><td class="cell">Mixed population</td><td class="cell">Neurons could be generated from all healthy subjects’</td></tr><tr><td class="cell">et al. (2015)</td><td class="cell">Retroviral vector (vector</td><td class="cell">(BPD Type 1)</td><td class="empty"></td><td class="cell">iPSC but only 2/6 BPD iPSC lines. NPCs could be</td></tr><tr><td class="empty"></td><td class="cell">(OCT4, SOX2, KLF4,</td><td class="cell">GM05224 GM05225</td><td class="empty"></td><td class="cell">generated from all lines, but not propagated beyond</td></tr><tr><td class="empty"></td><td class="cell">c-MYC))</td><td class="cell">Coriell Cell Repository</td><td class="empty"></td><td class="cell">4–5 passages. No expression of PAX6</td></tr><tr><td class="empty"></td><td class="cell">iPSC → NPC → iNeurons</td><td class="cell">Two parents (healthy)</td><td class="empty"></td><td class="cell">Bromodeoxyuridine staining (proliferation) ↓in BPD</td></tr><tr><td class="empty"></td><td class="cell">NPC medium, neurobasal</td><td class="cell">GM08330 GM08329</td><td class="empty"></td><td class="cell">NPCs</td></tr><tr><td class="empty"></td><td class="cell">medium</td><td class="empty"></td><td class="empty"></td><td class="cell">BPD neurons show ↓↓viability after 2 weeks of</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">differentiation; hardly any neurons were found</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">after 6 weeks</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">In iPSCs and fbroblasts, hardly any difference</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">between BPD and healthy subjects</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">In NPCs, 18 genes &gt; 1.5 fold expression</td></tr><tr><td class="cell">Mertens</td><td class="cell">Fibroblasts → iPSC → NPCs</td><td class="cell">Six cases, BPD Type 1</td><td class="cell">Hippocampal dentate</td><td class="cell">Expression of mitochondrial genes in BPD ↑</td></tr><tr><td class="cell">et al. (2015)</td><td class="cell">Cyto-Tune Sendai</td><td class="cell">Recruited during a</td><td class="cell">gyrus (DG)</td><td class="cell">Overall smaller mitochondria</td></tr><tr><td class="empty"></td><td class="cell">reprogramming kit</td><td class="cell">prospective trial for</td><td class="cell">granule cell-like</td><td class="cell">mitochondrial function in JC-1 Assay in BPD ↑</td></tr><tr><td class="empty"></td><td class="cell">(commercial) → NPCs</td><td class="cell">Li+ monotherapy</td><td class="cell">neurons</td><td class="cell">Increased excitability in BPD iPSC neurons. Altered</td></tr><tr><td class="empty"></td><td class="cell">DKK1 Cyclopamine,</td><td class="cell">(three Li+ responders,</td><td class="cell">&gt; 80% VGLUT1+</td><td class="cell">action potential frequency, Ca++ signalling PKA/C</td></tr><tr><td class="empty"></td><td class="cell">Noggin → iNeurons</td><td class="cell">three Li+</td><td class="cell">2–7% GABAergic</td><td class="cell">signalling.</td></tr><tr><td class="empty"></td><td class="cell">WNT3A, BDNF</td><td class="cell">non-responders)</td><td class="cell">(characterized by</td><td class="cell">In Li+ responders, action potential frequency was</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="cell">Four healthy subjects</td><td class="cell">GABA release)</td><td class="cell">attenuated by Li+ but not in non-responders. Li+ alters</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">gene expression differently in responders and</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">non-responders and seems to rescue disease relevant</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">genes. Li+ increases mitochondria size.</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">Electrophysiological alterations in non-responders</td></tr><tr><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="empty"></td><td class="cell">were attenuated by lamotrigine</td></tr><tr><td class="cell">Bavamian</td><td class="cell">iPSC → NPCs</td><td class="cell">iPSC: I case BPD type 1</td><td class="cell">Not stated</td><td class="cell">miRNA-34a ↑in BPD patient cerebellum slices</td></tr><tr><td class="cell">et al. (2015)</td><td class="cell">Retroviral vector (vector</td><td class="cell">Coriell Cell Repository</td><td class="empty"></td><td class="cell">(without Li+ treatment) as well as in both cell models</td></tr><tr><td class="empty"></td><td class="cell">(OCT4, SOX2, KLF4,</td><td class="cell">GM05224 and one</td><td class="empty"></td><td class="cell">25 putative miR-34a targets were identifed. ANK3,</td></tr><tr><td class="empty"></td><td class="cell">c-MYC))</td><td class="cell">healthy subject</td><td class="empty"></td><td class="cell">CACNA1C, CACNB3, ODZ4, DDN, and KLC2</td></tr><tr><td class="empty"></td><td class="cell">NPCs→iNeurons</td><td class="cell">GM08330</td><td class="empty"></td><td class="cell">overlap with BPD GWAS loci.</td></tr><tr><td class="empty"></td><td class="cell">In NPC and neuronal</td><td class="cell">iN fve cases</td><td class="empty"></td><td class="cell">miRNA-34a targets were downregulated with increased</td></tr><tr><td class="empty"></td><td class="cell">differentiation media</td><td class="cell">BPD type 1</td><td class="empty"></td><td class="cell">expression of the miRNA in NPCs and early neurons</td></tr><tr><td class="empty"></td><td class="cell">Fibroblasts → iNeuron:</td><td class="empty"></td><td class="empty"></td><td class="cell">derived from a BPD patient.</td></tr><tr><td class="empty"></td><td class="cell">direct conversion from</td><td class="empty"></td><td class="empty"></td><td class="cell">ANK3 and CACNB3 were up regulated as miRNA-34a</td></tr><tr><td class="empty"></td><td class="cell">fbroblasts</td><td class="empty"></td><td class="empty"></td><td class="cell">was blocked in healthy subject and BPD-derived iPSC</td></tr><tr><td class="empty"></td><td class="cell">Lentiviral vector</td><td class="empty"></td><td class="empty"></td><td class="cell">neurons.</td></tr><tr><td class="empty"></td><td class="cell">(miRNA-9/9*-123,</td><td class="empty"></td><td class="empty"></td><td class="cell">miRNA-34a impairs pre- and post-synaptic</td></tr><tr><td class="empty"></td><td class="cell">NEUROD2, ASCL1,</td><td class="empty"></td><td class="empty"></td><td class="cell">development; dentritic branching ↓</td></tr><tr><td class="empty"></td><td class="cell">MYT1L)</td><td class="empty"></td><td class="empty"></td><td class="empty"></td></tr></table></body></html>